Discontinuation of first-line chemotherapy (CT) after 6 weeks of CT in patients (pts) with metastatic squamous-cell esophageal cancer (MSEC): A randomized phase II trial.

Antoine Adenis; Jaafar Bennouna; Pierre-Luc Etienne; Emilie Bogart; Eric Francois; Marie-Pierre Galais; Meher Ben Abdelghani; Nuria Kotecki; Pierre Michel; Jean-Philippe Metges; Laetitia Dahan; Guillaume Piessen; Thierry Conroy; Francois Ghiringhelli; Laurent Bedenne; Farid El Hajbi; Emmanuelle Samalin; Stephanie Clisant Delaine; Nicolas Penel; Christophe Mariette

doi:10.1200/jco.2016.34.15_suppl.4002

Discontinuation of first-line chemotherapy (CT) after 6 weeks of CT in patients (pts) with metastatic squamous-cell esophageal cancer (MSEC): A randomized phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4002 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4002-4002 ◽

Cited By ~ 1

Author(s):

Antoine Adenis ◽

Jaafar Bennouna ◽

Pierre-Luc Etienne ◽

Emilie Bogart ◽

Eric Francois ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

First Line ◽

Squamous Cell Esophageal Cancer ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdz278 ◽

2019 ◽

Vol 30 (10) ◽

pp. 1613-1621 ◽

Cited By ~ 10

Author(s):

J.M. Weiss ◽

T. Csoszi ◽

M. Maglakelidze ◽

R.J. Hoyer ◽

J.T. Beck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Phase Ib ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Final results of randomized phase II trial of metronomic vs weekly oral vinorelbine (OV) as first-line chemotherapy (CT) in advanced NSCLC patients unfit to platinum-based CT (P-CT): Tempo-Lung

Annals of Oncology ◽

10.1093/annonc/mdz260.091 ◽

2019 ◽

Vol 30 ◽

pp. v646 ◽

Cited By ~ 1

Author(s):

D.M. Kowalski ◽

A. Morabito ◽

A. Montanino ◽

R. Bernabé ◽

F. Grossi ◽

...

Keyword(s):

Phase Ii ◽

Advanced Nsclc ◽

Phase Ii Trial ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Nsclc Patients ◽

Line Chemotherapy

Download Full-text

A multicenter phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15520 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15520-15520 ◽

Cited By ~ 1

Author(s):

J. Kim ◽

H. Song ◽

Y. Do ◽

M. Kim ◽

K. Lee ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

Squamous Cell Esophageal Cancer

Download Full-text

Randomized Phase II Trial of Capecitabine Plus Cisplatin Versus Paclitaxel as First Line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Annals of Oncology ◽

10.1093/annonc/mdt203.59 ◽

2013 ◽

Vol 24 ◽

pp. iv53

Author(s):

Su Jin Lee ◽

Silvia Park ◽

Wonjin Chang ◽

Jung Yong Hong ◽

Moon Ki Choi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A prospective, open-label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first-line chemotherapy in patients with androgen-independent prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4678 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4678-4678 ◽

Cited By ~ 1

Author(s):

S. Tomek ◽

K. Elandt ◽

P. Horak ◽

W. Albrecht ◽

M. Eisenmenger ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Open Label ◽

Weekly Docetaxel ◽

Randomized Phase Ii ◽

Line Chemotherapy ◽

Androgen Independent

Download Full-text

Re: Vinflunine-gemcitabine Versus Vinflunine-carboplatin as First-line Chemotherapy in Cisplatin-unfit Patients with Advanced Urothelial Carcinoma: Results of an International Randomized Phase II Trial (JASINT1)

European Urology ◽

10.1016/j.eururo.2016.03.066 ◽

2016 ◽

Vol 70 (2) ◽

pp. 399-400

Author(s):

Georgios Gakis

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Randomized Phase Ii ◽

Unfit Patients ◽

Advanced Urothelial Carcinoma ◽

Line Chemotherapy

Download Full-text

Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial

Value in Health ◽

10.1016/j.jval.2020.11.017 ◽

2021 ◽

Vol 24 (5) ◽

pp. 676-682 ◽

Cited By ~ 1

Author(s):

Sophie Marguet ◽

Antoine Adenis ◽

Stéphanie Delaine-Clisant ◽

Nicolas Penel ◽

Julia Bonastre

Keyword(s):

Esophageal Cancer ◽

Economic Evaluation ◽

Squamous Cell ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

First Line ◽

Squamous Cell Esophageal Cancer ◽

Line Chemotherapy

Download Full-text

Phase II trial of paclitaxel and cisplatin combination given biweekly as first-line chemotherapy in patients with advanced or metastatic squamous cell carcinoma of esophagus from a single center in China.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e14646 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e14646-e14646

Author(s):

Y. Zhou ◽

J. Huang ◽

L. Yang ◽

G. R. Cai ◽

H. B. Xu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Single Center ◽

First Line ◽

Metastatic Squamous Cell Carcinoma ◽

Carcinoma Of Esophagus ◽

Line Chemotherapy

Download Full-text

A Randomized Phase II Trial of Biweekly S-1 with Paclitaxel (SPA) or Oxaliplatin (SOX) as First-Line Chemotherapy in advanced Gastric Cancer Patients: Preliminary Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33249-x ◽

2012 ◽

Vol 23 ◽

pp. ix256

Author(s):

M. Haibo ◽

W. Fang ◽

Y. Zheng ◽

P. Zhao ◽

C. Mao ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Preliminary Results ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text